193 related articles for article (PubMed ID: 15467570)
21. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
Langer O; Yogev Y; Xenakis EM; Rosenn B
Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy outcome in obese and morbidly obese gestational diabetic women.
Yogev Y; Langer O
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):21-6. PubMed ID: 17517462
[TBL] [Abstract][Full Text] [Related]
23. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy.
Murphy HR; Rayman G; Duffield K; Lewis KS; Kelly S; Johal B; Fowler D; Temple RC
Diabetes Care; 2007 Nov; 30(11):2785-91. PubMed ID: 17666464
[TBL] [Abstract][Full Text] [Related]
24. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance.
Di Cianni G; Miccoli R; Volpe L; Lencioni C; Ghio A; Giovannitti MG; Cuccuru I; Pellegrini G; Chatzianagnostou K; Boldrini A; Del Prato S
Diabet Med; 2005 Jan; 22(1):21-5. PubMed ID: 15606686
[TBL] [Abstract][Full Text] [Related]
25. [Fetal growth and glycemic control in type 1 diabetes pregnancy].
Campos MV; Ruas L; Paiva S; Leitão P; Lobo C; Marta E; Sobral E; Cravo A; Carvalheiro M
Acta Med Port; 2004; 17(2):167-72. PubMed ID: 15921648
[TBL] [Abstract][Full Text] [Related]
26. Effect of glycemic index on whole-body substrate oxidation in obese women.
Díaz EO; Galgani JE; Aguirre CA; Atwater IJ; Burrows R
Int J Obes (Lond); 2005 Jan; 29(1):108-14. PubMed ID: 15505637
[TBL] [Abstract][Full Text] [Related]
27. Glycemic level at the first visit and prediction of GDM.
Seshiah V; Balaji V; Balaji MS; Panneerselvam A; Thamizharasi M; Arthi T
J Assoc Physicians India; 2007 Sep; 55():630-2. PubMed ID: 18051734
[TBL] [Abstract][Full Text] [Related]
28. Predicting more accurately the overall glucose response to a lunch meal by using the postprandial glucose peak.
Chapelot D; Marmonier C; Valensi P
Metabolism; 2007 Jan; 56(1):37-43. PubMed ID: 17161224
[TBL] [Abstract][Full Text] [Related]
29. Influence of BMI and gender on postprandial hormone responses.
Carroll JF; Kaiser KA; Franks SF; Deere C; Caffrey JL
Obesity (Silver Spring); 2007 Dec; 15(12):2974-83. PubMed ID: 18198306
[TBL] [Abstract][Full Text] [Related]
30. Prediction of postprandial glycemic exposure: utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength.
Cohen O; Basu R; Bock G; Dalla Man C; Campioni M; Basu A; Toffolo G; Cobelli C; Rizza RA
Diabetes Care; 2006 Dec; 29(12):2708-13. PubMed ID: 17130209
[TBL] [Abstract][Full Text] [Related]
31. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
Schreuder T; Karreman M; Rennings A; Ruinemans-Koerts J; Jansen M; de Boer H
Diabetes Obes Metab; 2005 May; 7(3):239-45. PubMed ID: 15811140
[TBL] [Abstract][Full Text] [Related]
32. [Correlation between amniotic fluid glucose concentration and amniotic fluid volume and neonatal birth weight in pregnancy complicated by gestational diabetes mellitus].
Xu ZM; Wu LF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):724-8. PubMed ID: 17327026
[TBL] [Abstract][Full Text] [Related]
33. Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients.
Pistrosch F; Reissmann E; Wildbrett J; Koehler C; Hanefeld M
Am J Hypertens; 2007 May; 20(5):541-5. PubMed ID: 17485018
[TBL] [Abstract][Full Text] [Related]
34. Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects.
Adam TC; Jocken J; Westerterp-Plantenga MS
Obes Res; 2005 Apr; 13(4):710-6. PubMed ID: 15897480
[TBL] [Abstract][Full Text] [Related]
35. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
[TBL] [Abstract][Full Text] [Related]
36. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
37. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus.
Endo S; Maeda K; Suto M; Kaji T; Morine M; Kinoshita T; Yasui T; Irahara M
Gynecol Endocrinol; 2006 Jun; 22(6):343-9. PubMed ID: 16785160
[TBL] [Abstract][Full Text] [Related]
38. Heart sympathetic activity and pulmonary function in obese pregnant women.
Amador-Licona N; Guízar-Mendoza JM; Juárez M; Linares-Segovia B
Acta Obstet Gynecol Scand; 2009; 88(3):314-9. PubMed ID: 19241226
[TBL] [Abstract][Full Text] [Related]
39. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
40. Maternal obesity is a major risk factor for large-for-gestational-infants in pregnancies complicated by gestational diabetes.
Ben-Haroush A; Hadar E; Chen R; Hod M; Yogev Y
Arch Gynecol Obstet; 2009 Apr; 279(4):539-43. PubMed ID: 18758799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
